推荐产品
化驗
>99% (LPC; may contain up to 10% of the 2-LPC isomer, TLC)
形狀
powder
包裝
pkg of 1 × 1 mg (860389P-1mg)
pkg of 1 × 5 mg (860389P-5mg)
製造商／商標名
Avanti Polar Lipids 860389P
運輸包裝
dry ice
儲存溫度
−20°C
一般說明
26:0-d4 Lyso PC是氘代溶血磷脂酰胆碱（Lyso PC），其中4个二十六烷酰基质子被氘取代。
應用
26:0-d4 Lyso PC已用作内标，以从大脑、睾丸和肾上腺中提取总超长链脂肪酸（VLCFA）。
包裝
5 mL棕色玻璃螺旋盖小瓶（860389P-1mg）
5 mL棕色玻璃螺旋盖小瓶（860389P-5mg）
法律資訊
Avanti Research is a trademark of Avanti Polar Lipids, LLC
儲存類別代碼
11 - Combustible Solids
Walter C Hubbard et al.
Molecular genetics and metabolism, 97(3), 212-220 (2009-05-09)
Newborn screening for X-linked adrenoleukodystrophy (X-ALD) has until now been limited in implementation because of the lack of an accepted standard methodology. We have previously reported a technique using LC-MS/MS analysis that could provide the basis for screening of newborns
Wedad Fallatah et al.
Disease models & mechanisms, 13(1) (2019-12-22)
Rhizomelic chondrodysplasia punctata (RCDP) is a rare genetic disorder caused by mutations in peroxisomal genes essential for plasmalogen biosynthesis. Plasmalogens are a class of membrane glycerophospholipids containing a vinyl-ether-linked fatty alcohol at the sn-1 position that affect functions including vesicular
A thyroid hormone-based strategy for correcting the biochemical abnormality in X-linked adrenoleukodystrophy
Hartley MD, et al.
Endocrinology, 158(5), 1328-1338 (2017)
John Williams et al.
Bioanalysis, 12(3), 143-158 (2020-02-14)
Aim: Very long chain fatty acids (VLCFAs) have been identified as biomarkers for several peroxisomal disorders necessitating the need for reliable biomarker assays in particular C20, C22, C24, C26 in cerebrospinal fluid (CSF). Until now no absolute quantitation assay for
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门